In a paper published Feb. 28 in the journal eLife, a team of researchers headed by Princeton’s Alexander Ploss settle a debate about a key protein in hepatitis E (Hep E), which could open the way to developing treatments for a tiny virus that poses an outsized threat to public health around the globe. Read More